Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma - 101827

Spotlight
Video

Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma

Loading........
Description: Jason Luke, MD of the University of Chicago discusses Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma
Shared By : GiantsOfCancerCare
Posted on : 06/17/15
Added : 3 years ago



Recommended

Nothing found.

More From GiantsOfCancerCare

Nothing found.